KURN — Kuros Biosciences AG Share News
0.000.00%
- CH₣828.53m
- CH₣831.76m
- $146.06m
Brief: Kuros To Receive $4 Million Milestone Payment From Checkmate Pharmaceuticals
Brief: Kuros To Get $2 Mln Payment From Checkmate Pharmaceuticals
Brief: Kuros FY Revenues Up At CHF 4.0 Million
Brief: Kuros Signs New Sales And Distribution Agreements For Magnetos Bone Graft
Brief: Kuros Raises CHF 18.6 Million In Capital Increase
Brief: Kuros Provides Update On Planned Capital Increase
Brief: Kuros Biosciences To Present New Data On Role Of Osteoimmunology
Swiss stocks - Factors to watch on Tuesday October 6
Brief: Kuros Biosciences AG Says All Agenda Items Were Approved At Its Extraordinary General Meeting
Brief: Kuros Biosciences To Hold EGM To Seek Approval for Share Capital Increase
Brief: Kuros Biosciences Treatment Of First Patient In Its Spinal Fusion Trial With Fibrin-PTH
Brief: Kuros Biosciences H1 Net Loss Widens To CHF 5.8 Million
Brief: Kuros Biosciences FY Revenues Up At CHF 2.6 Million
Brief: Kuros Announces Grant Of U.S. Patent For PTH With Matrices For Spinal Fusion
Swiss stocks - Factors to watch on March 18
Brief: Kuros Biosciences Reports Publication Of Magnetos Preclinical Data
Swiss stocks - Factors to watch on December 4
Brief: Kuros Raises Gross Proceeds Of CHF 12.5 Mln Through Capital Increase
Brief: Kuros Biosciences Announces Results Of Rights Offering